Monday, July 20, 2020 1:29:34 PM
Newly announced CytoDyn Scientific Advisory Board member Dr. Hope S. Rugo will be featured on Research To Practice tonight:
Recent Advances in Medical Oncology:
Focus on Triple-Negative Breast Cancer
Part 6 of a 14-Part CME Webinar Series Held in
Conjunction with ASCO20 Virtual
Monday, July 20 — 5:00 PM - 6:00 PM ET
Access Tonight's Webinar: https://us02web.zoom.us/webinar/register/WN_olnKrJvGQg2eBvm0prFz7w
Our summer webinar series held in partnership with the American Society of Clinical Oncology continues tonight at 5 PM ET as Drs Joyce O’Shaughnessy and Hope S Rugo join me to share their perspectives on optimal targeted treatment approaches for patients with triple-negative breast cancer and touch on how the COVID-19 pandemic has affected the delivery of cancer care.///
As a "family caregiver" to a 10-year BC patient (ILC)(10 years!!!) who's tried to keep apprised of most things BC, Dr. Rugo is no stranger. Dr. Rugo is a well known practitioner, researcher, educator. I'm thrilled she is with CytoDyn!
Recent Advances in Medical Oncology:
Focus on Triple-Negative Breast Cancer
Part 6 of a 14-Part CME Webinar Series Held in
Conjunction with ASCO20 Virtual
Monday, July 20 — 5:00 PM - 6:00 PM ET
Access Tonight's Webinar: https://us02web.zoom.us/webinar/register/WN_olnKrJvGQg2eBvm0prFz7w
Our summer webinar series held in partnership with the American Society of Clinical Oncology continues tonight at 5 PM ET as Drs Joyce O’Shaughnessy and Hope S Rugo join me to share their perspectives on optimal targeted treatment approaches for patients with triple-negative breast cancer and touch on how the COVID-19 pandemic has affected the delivery of cancer care.///
As a "family caregiver" to a 10-year BC patient (ILC)(10 years!!!) who's tried to keep apprised of most things BC, Dr. Rugo is no stranger. Dr. Rugo is a well known practitioner, researcher, educator. I'm thrilled she is with CytoDyn!
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
